3386
COSMO BIO COMPANY,LIMITED
コスモ・バイオ
- Industry
- Wholesale Trade
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Dec 2021
9,231
Dec 2022
9,553
Dec 2023
9,340
Dec 2024
10,037
Dec 2025
10,766
Operating profit(million JPY)
Dec 2021
1,048
Dec 2022
816
Dec 2023
519
Dec 2024
318
Dec 2025
343
Operating profit margin(%)
Dec 2021
11.35
Dec 2022
8.54
Dec 2023
5.56
Dec 2024
3.17
Dec 2025
3.19
Profit before tax(million JPY)
Dec 2021
1,099
Dec 2022
790
Dec 2023
653
Dec 2024
369
Dec 2025
504
Profit(million JPY)
Dec 2021
737
Dec 2022
517
Dec 2023
442
Dec 2024
262
Dec 2025
337
Total assets(million JPY)
Dec 2021
10,072
Dec 2022
10,313
Dec 2023
10,872
Dec 2024
11,723
Dec 2025
12,662
Cash and cash equivalents(million JPY)
Dec 2021
3,255
Dec 2022
3,036
Dec 2023
2,826
Dec 2024
2,393
Dec 2025
2,747
Cash flows from operating activities(million JPY)
Dec 2021
648
Dec 2022
284
Dec 2023
736
Dec 2024
241
Dec 2025
595
Cash flows from investing activities(million JPY)
Dec 2021
-145
Dec 2022
-291
Dec 2023
-758
Dec 2024
-217
Dec 2025
43
Cash flows from financing activities(million JPY)
Dec 2021
-420
Dec 2022
-236
Dec 2023
-201
Dec 2024
-479
Dec 2025
-283
Return on equity(%)
Dec 2021
9.7
Dec 2022
6.5
Dec 2023
5.4
Dec 2024
3
Dec 2025
3.6
Equity ratio(%)
Dec 2021
77.3
Dec 2022
78.1
Dec 2023
77.7
Dec 2024
76.5
Dec 2025
74
Earnings per share(JPY per share)
Dec 2021
126.94
Dec 2022
89.13
Dec 2023
75.97
Dec 2024
45.05
Dec 2025
59.26
Net assets per share(JPY per share)
Dec 2021
1,344.48
Dec 2022
1,385.2
Dec 2023
1,447.08
Dec 2024
1,565
Dec 2025
1,652.02
Dividend per share(JPY per share)
Dec 2021
36
Dec 2022
36
Dec 2023
30
Dec 2024
50
Dec 2025
50
Payout ratio(%)
Dec 2021
28.36
Dec 2022
40.39
Dec 2023
39.49
Dec 2024
110.99
Dec 2025
84.37
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.